We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biochip Combines Graphene Electronics and DNA Strand Displacement for Detection of Polymorphism Mutations

By LabMedica International staff writers
Posted on 05 Jul 2016
Print article
Image: The biosensor chip - consisting of a double stranded DNA probe embedded onto a graphene transistor - electronically detects DNA SNPs (Photo courtesy of the University of California, San Diego).
Image: The biosensor chip - consisting of a double stranded DNA probe embedded onto a graphene transistor - electronically detects DNA SNPs (Photo courtesy of the University of California, San Diego).
A team of bioengineers has designed an electronic biochip with potential applications for personalized medicine that can detect DNA mutations caused by single nucleotide polymorphisms (SNPs) in real time.

SNPs, which are variations of a single nucleotide base, in a gene sequence are markers for a variety of human diseases. Detection of SNPs with high specificity and sensitivity is essential for effective practical implementation of personalized medicine. However, current DNA sequencing, including SNP detection, primarily uses enzyme-based methods or fluorophore-labeled assays that are time-consuming, need laboratory-scale settings, and are expensive. Previously reported electrical charge-based SNP detectors have insufficient specificity and accuracy, limiting their effectiveness.

In an effort to improve the accuracy and specificity of SNP detection, investigators at the University of California, San Diego (USA) combined dynamic DNA nanotechnology with high resolution electronic sensing in the form of a double stranded DNA probe embedded onto a graphene field effect transistor (FET).

The detection method was based on the displacement of a weakly bound DNA double strand by one containing a specific SNP. The single mismatch was detected by measuring strand displacement-induced resistance (and hence current) change in the graphene transistor. Use of large double-helix DNA strands (up to 47 bases) improved the accuracy of SNP detection by minimizing false-positive results.

“A single stranded DNA probe does not provide this selectivity - even a DNA strand containing one mismatching nucleotide base can bind to the probe and generate false-positive results,” said senior author Dr. Ratnesh Lal, professor of bioengineering, mechanical engineering, and materials science at the University of California, San Diego. “We expected that with a longer probe, we can develop a reliable sequence-specific SNP detection chip. Indeed, we have achieved a high level of sensitivity and specificity with the technology we have developed.”

“We are at the forefront of developing a fast and inexpensive digital method to detect gene mutations at high resolution—on the scale of a single nucleotide change in a nucleic acid sequence,” said Dr. Lal.

The SNP biosensor probe was described in detail in the June 13, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences.

Related Links:
University of California, San Diego


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.